drugset / Trial / NCT01928368
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if a single dose of AMG 282 is safe in healthy subjects and subjects with mild atopic asthma.
Timeline
- Start
- 2013-08
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Astegolimab | Monoclonal antibody | — | Subcutaneous |